Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 19 April 2022

Yesterday’s UK 100 Leaders Price (p) % Chg
INTERCONTINENTAL HOTELS GROU 5,192.0 4.1%
ROLLS-ROYCE HOLDINGS PLC 93.4 3.8%
INTL CONSOLIDATED AIRLINE-DI 145.5 3.7%
WHITBREAD PLC 2,915.0 3.7%
LAND SECURITIES GROUP PLC 770.8 3.0%
Yesterday’s UK 100 Laggards Price (p) % Chg
DECHRA PHARMACEUTICALS PLC 3822.0 -6.4%
ITV PLC 77.0 -2.6%
FRESNILLO PLC 804.0 -2.3%
OCADO GROUP PLC 1138.5 -1.3%
COCA-COLA HBC AG-DI 1583.0 -1.0%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,616 0.5% 9.1%
DOW JONES INDUS. AVG 34,412 -0.1% 1.1%
DAX INDEX 14,164 0.6% -7.2%
NIKKEI 225 26,800 -1.1% -9.7%
S&P/ASX 200 INDEX 7,523 0.6% 6.6%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 107.50 0.51%
Brent Crude (ICE) USD/bbl. 112.53 0.74%
Gold Spot USD/t oz. 1,978 0.0%
Copper (Comex) USd/lb. 482 1.7%
The UK 100 is called to open flat at 7616. 

1 day; 2 Years

Click graph to enlarge

Markets Overview:

 

The UK 100 is called to open flat at 7616.   The UK’s bluechip index is called to open flat this morning with no change over the bank holiday weekend.  Wall Street finished slightly in the red overnight, and Asian shares follow suit and are mostly in the red this morning.  The Shanghai Composite in China declined 0.42% while Hong Kong’s Hang Seng index slumped 2.41%.  Japan's Nikkei gained 0.81% and South Korea’s Kospi surged 0.97%.

Company News & Broker Comments:

 

Company News:

AstraZeneca's Enhertu application has been granted priority review by the FDA for lung cancer.

 

 

GlaxoSmithKline says the US FDA accepts their new drug application for daprodustat kidney disease drug.

 

 

Pearson states that their online programme management partnership with ASU will end in June 2023, noting a modest impact on profit in 2022 & 2023.

 

 

WH Smith says their subsidiary Funky Pigeon was hit by a cyber-attack last Thursday, but did not breach customer payment data. They confirm H1 results are "comfortably in line" with company compiled consenus.

Broker Comments:

 

Barclays Upgrades CRH to Overweight from Equal Weight (5 Buys / 0 Holds / 0 Sells)

 

 

Berenberg Downgrades ITV to Sell from Hold (5 Buys / 7 Holds / 1 Sell)

 

 

Deutsche Bank Downgrades SSP Group to Hold from Buy (11 Buys / 4 Holds / 0 Sells)

 

 

Societe Generale Upgrades Prudential to Buy from Hold (9 Buys / 2 Holds / 1 Sell)

 

Reporting Today:

 

JTC

 

Kainos

 

Reporting Tomorrow:

Bunzl

 

Centamin

 

IntegraFin Holdings

 

Oxford BioMedica

 

Petershill Partners

 

Quilter

 

Wood Group (John)

 

 

In Focus Today:

IMF Meeting

 

RBA Meeting Minutes

 

Japanese Industrial Production

 

US Housing Starts

 

Japanese Merchandise Trade Balance Total

 

 

This Week's Ex-Dividends:

 

FTSE 100:

Antofagasta

 

Legal & General Group

 

BAE Systems

 

Glencore

 

Spirax-Sarco Engineering

 

FTSE 250:

Jupiter Fund Management

 

Provident Financial

 

Rathbones Group

 

Bodycote

 

Genuit Group

 

Essentra

 

Bridgepoint Group

 

Just Group

 

Weir Group

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.